Literature DB >> 16444918

Diabetes insipidus: diagnosis and treatment of a complex disease.

Amgad N Makaryus1, Samy I McFarlane.   

Abstract

Diabetes insipidus, characterized by excretion of copious volumes of dilute urine, can be life-threatening if not properly diagnosed and managed. It can be caused by two fundamentally different defects: inadequate or impaired secretion of antidiuretic hormone (ADH) from the posterior pituitary gland (neurogenic or central diabetes insipidus) or impaired or insufficient renal response to ADH (nephrogenic diabetes insipidus). The distinction is essential for effective treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16444918     DOI: 10.3949/ccjm.73.1.65

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  20 in total

1.  Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.

Authors:  Duygu Duzenli; Emel Saglar; Ferhat Deniz; Omer Azal; Beril Erdem; Hatice Mergen
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.

Authors:  Emel Saglar; Ferhat Deniz; Beril Erdem; Tugce Karaduman; Arif Yönem; Eylem Cagiltay; Hatice Mergen
Journal:  Endocrine       Date:  2013-09-13       Impact factor: 3.633

3.  Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation.

Authors:  Theo Diamandis; Chiara Gonzales-Portillo; Gabriel S Gonzales-Portillo; Meaghan Staples; Mia C Borlongan; Diana Hernandez; Sandra Acosta; Cesar V Borlongan
Journal:  Med Hypotheses       Date:  2013-08-30       Impact factor: 1.538

4.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

Review 5.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

6.  Post-operative diabetes insipidus after endoscopic transsphenoidal surgery.

Authors:  Matthew Schreckinger; Blake Walker; Jordan Knepper; Mark Hornyak; David Hong; Jung-Min Kim; Adam Folbe; Murali Guthikonda; Sandeep Mittal; Nicholas J Szerlip
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

7.  Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption.

Authors:  Jessica Y S Chu; Samuel C K Chung; Amy K M Lam; Sidney Tam; Sookja K Chung; Billy K C Chow
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

Review 8.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

9.  3T renal (23)Na-MRI: effects of desmopressin in patients with central diabetes insipidus.

Authors:  Stefan Haneder; Henrik J Michaely; Simon Konstandin; Lothar R Schad; John N Morelli; Bernhard K Krämer; Stefan O Schoenberg; Alexander Lammert
Journal:  MAGMA       Date:  2013-04-06       Impact factor: 2.310

Review 10.  Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system.

Authors:  Fabio Rotondo; Henriett Butz; Luis V Syro; George M Yousef; Antonio Di Ieva; Lina M Restrepo; Andres Quintanar-Stephano; Istvan Berczi; Kalman Kovacs
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.